I think they will weed out any sellers and flippers now, before they jack it up to $2-$3 next. Cytrex and Kerix Pharmas did the same thing last year and the final rallies took those biotech stocks way beyond reasonable prices based on the last 6 years. In fact is MSTX follows the same path, $4 to $5 is possible.
I think $2 is a reasonable top, but what do I know, I got out of the last 3 too soon.